HKSE - Delayed Quote HKD

CHINA HEALTH (0673.HK)

0.140
-0.005
(-3.45%)
At close: April 30 at 4:08:15 PM GMT+8
Loading Chart for 0673.HK
  • Previous Close 0.145
  • Open 0.145
  • Bid 0.140 x --
  • Ask 0.145 x --
  • Day's Range 0.132 - 0.151
  • 52 Week Range 0.132 - 1.040
  • Volume 1,080,000
  • Avg. Volume 634,770
  • Market Cap (intraday) 68.83M
  • Beta (5Y Monthly) -1.29
  • PE Ratio (TTM) --
  • EPS (TTM) -0.090
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

China Health Group Limited, an investment holding company, engages in the distribution and services of medical equipment and consumables in the People's Republic of China. The company operates through Distribution and Service in Medical Equipment and Consumables; Hospital Operation and Management Services; Business Service; and Research and Development and Sale of Functional Food segments. It is involved in the distribution and marketing of pharmaceutical products, as well as property investment and factoring services business. The company was formerly known as China HealthCare Holdings Limited and changed its name to China Health Group Limited in September 2015. The company was incorporated in 2001 and is headquartered in Central, Hong Kong.

www.ch-groups.com

118

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 0673.HK

View More

Performance Overview: 0673.HK

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0673.HK
43.09%
HANG SENG INDEX (^HSI)
14.00%

1-Year Return

0673.HK
84.78%
HANG SENG INDEX (^HSI)
23.36%

3-Year Return

0673.HK
74.55%
HANG SENG INDEX (^HSI)
14.33%

5-Year Return

0673.HK
73.58%
HANG SENG INDEX (^HSI)
5.62%

Compare To: 0673.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0673.HK

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    68.83M

  • Enterprise Value

    71.96M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.34

  • Price/Book (mrq)

    1.57

  • Enterprise Value/Revenue

    1.43

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -84.45%

  • Return on Assets (ttm)

    -7.22%

  • Return on Equity (ttm)

    -66.07%

  • Revenue (ttm)

    50.34M

  • Net Income Avi to Common (ttm)

    -42.51M

  • Diluted EPS (ttm)

    -0.090

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.41M

  • Total Debt/Equity (mrq)

    10.78%

  • Levered Free Cash Flow (ttm)

    -23.56M

Research Analysis: 0673.HK

View More

Company Insights: 0673.HK

Research Reports: 0673.HK

View More

People Also Watch